These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
264 related articles for article (PubMed ID: 19895918)
1. CRTAP deficiency leads to abnormally high bone matrix mineralization in a murine model and in children with osteogenesis imperfecta type VII. Fratzl-Zelman N; Morello R; Lee B; Rauch F; Glorieux FH; Misof BM; Klaushofer K; Roschger P Bone; 2010 Mar; 46(3):820-6. PubMed ID: 19895918 [TBL] [Abstract][Full Text] [Related]
2. Non-Lethal Type VIII Osteogenesis Imperfecta Has Elevated Bone Matrix Mineralization. Fratzl-Zelman N; Barnes AM; Weis M; Carter E; Hefferan TE; Perino G; Chang W; Smith PA; Roschger P; Klaushofer K; Glorieux FH; Eyre DR; Raggio C; Rauch F; Marini JC J Clin Endocrinol Metab; 2016 Sep; 101(9):3516-25. PubMed ID: 27383115 [TBL] [Abstract][Full Text] [Related]
3. Genetic Analysis, Phenotypic Spectrum and Functional Study of Rare Osteogenesis Imperfecta Caused by CRTAP Variants. Zhou B; Gao P; Hu J; Lin X; Sun L; Zhang Q; Jiang Y; Wang O; Xia W; Xing X; Li M J Clin Endocrinol Metab; 2024 Jun; 109(7):1803-1813. PubMed ID: 38214665 [TBL] [Abstract][Full Text] [Related]
4. Sclerostin Antibody Treatment Improves the Bone Phenotype of Crtap(-/-) Mice, a Model of Recessive Osteogenesis Imperfecta. Grafe I; Alexander S; Yang T; Lietman C; Homan EP; Munivez E; Chen Y; Jiang MM; Bertin T; Dawson B; Asuncion F; Ke HZ; Ominsky MS; Lee B J Bone Miner Res; 2016 May; 31(5):1030-40. PubMed ID: 26716893 [TBL] [Abstract][Full Text] [Related]
5. Alterations of bone material properties in growing Ifitm5/BRIL p.S42 knock-in mice, a new model for atypical type VI osteogenesis imperfecta. Hedjazi G; Guterman-Ram G; Blouin S; Schemenz V; Wagermaier W; Fratzl P; Hartmann MA; Zwerina J; Fratzl-Zelman N; Marini JC Bone; 2022 Sep; 162():116451. PubMed ID: 35654352 [TBL] [Abstract][Full Text] [Related]
6. Deficiency of CRTAP in non-lethal recessive osteogenesis imperfecta reduces collagen deposition into matrix. Valli M; Barnes AM; Gallanti A; Cabral WA; Viglio S; Weis MA; Makareeva E; Eyre D; Leikin S; Antoniazzi F; Marini JC; Mottes M Clin Genet; 2012 Nov; 82(5):453-9. PubMed ID: 21955071 [TBL] [Abstract][Full Text] [Related]
7. Tendon and motor phenotypes in the Grol MW; Haelterman NA; Lim J; Munivez EM; Archer M; Hudson DM; Tufa SF; Keene DR; Lei K; Park D; Kuzawa CD; Ambrose CG; Eyre DR; Lee BH Elife; 2021 May; 10():. PubMed ID: 34036937 [TBL] [Abstract][Full Text] [Related]
8. Hypermineralization and High Osteocyte Lacunar Density in Osteogenesis Imperfecta Type V Bone Indicate Exuberant Primary Bone Formation. Blouin S; Fratzl-Zelman N; Glorieux FH; Roschger P; Klaushofer K; Marini JC; Rauch F J Bone Miner Res; 2017 Sep; 32(9):1884-1892. PubMed ID: 28548288 [TBL] [Abstract][Full Text] [Related]
9. Unique micro- and nano-scale mineralization pattern of human osteogenesis imperfecta type VI bone. Fratzl-Zelman N; Schmidt I; Roschger P; Roschger A; Glorieux FH; Klaushofer K; Wagermaier W; Rauch F; Fratzl P Bone; 2015 Apr; 73():233-41. PubMed ID: 25554599 [TBL] [Abstract][Full Text] [Related]
10. Dental and craniofacial defects in the Crtap Xu H; Lenhart SA; Chu EY; Chavez MB; Wimer HF; Dimori M; Somerman MJ; Morello R; Foster BL; Hatch NE Dev Dyn; 2020 Jul; 249(7):884-897. PubMed ID: 32133710 [TBL] [Abstract][Full Text] [Related]
11. Correlations Between Bone Mechanical Properties and Bone Composition Parameters in Mouse Models of Dominant and Recessive Osteogenesis Imperfecta and the Response to Anti-TGF-β Treatment. Bi X; Grafe I; Ding H; Flores R; Munivez E; Jiang MM; Dawson B; Lee B; Ambrose CG J Bone Miner Res; 2017 Feb; 32(2):347-359. PubMed ID: 27649409 [TBL] [Abstract][Full Text] [Related]
12. Null mutations in LEPRE1 and CRTAP cause severe recessive osteogenesis imperfecta. Marini JC; Cabral WA; Barnes AM Cell Tissue Res; 2010 Jan; 339(1):59-70. PubMed ID: 19862557 [TBL] [Abstract][Full Text] [Related]
13. CRTAP and LEPRE1 mutations in recessive osteogenesis imperfecta. Baldridge D; Schwarze U; Morello R; Lennington J; Bertin TK; Pace JM; Pepin MG; Weis M; Eyre DR; Walsh J; Lambert D; Green A; Robinson H; Michelson M; Houge G; Lindman C; Martin J; Ward J; Lemyre E; Mitchell JJ; Krakow D; Rimoin DL; Cohn DH; Byers PH; Lee B Hum Mutat; 2008 Dec; 29(12):1435-42. PubMed ID: 18566967 [TBL] [Abstract][Full Text] [Related]
14. Fragility fractures in men with idiopathic osteoporosis are associated with undermineralization of the bone matrix without evidence of increased bone turnover. Fratzl-Zelman N; Roschger P; Misof BM; Nawrot-Wawrzyniak K; Pötter-Lang S; Muschitz C; Resch H; Klaushofer K; Zwettler E Calcif Tissue Int; 2011 May; 88(5):378-87. PubMed ID: 21318401 [TBL] [Abstract][Full Text] [Related]
15. Prolyl 3-hydroxylase 1 and CRTAP are mutually stabilizing in the endoplasmic reticulum collagen prolyl 3-hydroxylation complex. Chang W; Barnes AM; Cabral WA; Bodurtha JN; Marini JC Hum Mol Genet; 2010 Jan; 19(2):223-34. PubMed ID: 19846465 [TBL] [Abstract][Full Text] [Related]
16. CRTAP is required for prolyl 3- hydroxylation and mutations cause recessive osteogenesis imperfecta. Morello R; Bertin TK; Chen Y; Hicks J; Tonachini L; Monticone M; Castagnola P; Rauch F; Glorieux FH; Vranka J; Bächinger HP; Pace JM; Schwarze U; Byers PH; Weis M; Fernandes RJ; Eyre DR; Yao Z; Boyce BF; Lee B Cell; 2006 Oct; 127(2):291-304. PubMed ID: 17055431 [TBL] [Abstract][Full Text] [Related]